Position in NTRA
as of Jun 30, 2026
· filed Aug 18, 2026
Position Value
$12,363,731
+$3,326,785 QoQ
Shares Held
45,547
+0.8% QoQ
Ownership
0.032%
of shares outstanding
% of Portfolio
0.43%
of 13F equity value
Holder Rank
#184
of 846 holders
Holding Since
Mar 2025
6 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in NTRA Over Time
Shares Held
Position Value (USD)
Position in Diagnostics & Research
Healthcare · as of Jun 30, 2026Livforsakringsbolaget Skandia, Omsesidigt holds $15,650,720 across 9 Diagnostics & Research names. NTRA ranks #1 (79.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | NTRA |
Natera, Inc.
This page
|
45,547 | $12,363,731 | |
| 2 | TMO |
Thermo Fisher Scientific Inc.
|
2,419 | $1,212,789 | |
| 3 | DHR |
Danaher Corp /De/
|
5,307 | $1,010,877 | |
| 4 | IDXX |
Idexx Laboratories Inc /De
|
400 | $210,576 | |
| 5 | A |
Agilent Technologies, Inc.
|
1,531 | $203,362 | |
| 6 | DGX |
Quest Diagnostics Inc
|
889 | $188,423 | |
| 7 | ILMN |
Illumina, Inc.
|
1,047 | $184,094 | |
| 8 | LH |
Labcorp Holdings Inc.
|
552 | $154,560 |
All Filings in NTRA
Export CSV
6 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $12,363,731 | 45,547 | Shares | Sole | 2026-08-18 | |
| 2026-03-31 | $9,036,946 | 45,187 | Shares | Sole | 2026-05-05 | |
| 2025-12-31 | $2,087,925 | 9,114 | Shares | Sole | 2026-02-11 | |
| 2025-09-30 | $4,039,542 | 25,095 | Shares | Sole | 2025-11-18 | |
| 2025-06-30 | $1,350,675 | 7,995 | Shares | Sole | 2025-07-11 | |
| 2025-03-31 | $127,269 | 900 | Shares | Sole | 2025-04-15 | |
| No filing history on record for this holder in this stock. | ||||||